Thursday, November 16, 2023 |
||
| STAGE 1 | STAGE 2 | |
| 12:00pm - 12:30pm |
AMP Working Group: AMP/ASCO/CAP ISV Somatic Guideline Update |
Solving Challenges In Multiomic Testing Using The New Agilent Avida Dual-Target Enrichment Solution |
| 12:40pm - 1:10pm |
AMP Clinical Practice Committee Open Forum: Artificial Intelligence & Machine Learning - Impacts on Your Clinical Practice? |
The Revolution Sample Prep System for Liquid Biopsy – Overview and Performance Data |
| 3:45pm - 4:15pm |
Analytical performance of TruSight™ Oncology 500 ctDNA v2: Improved sensitivity for small nucleotide variants with reduced DNA input requirements and reduced hands-on time |
AMP Trainee and Early Career Series Hosted by: AMP`s Training and Education Committee |
| 4:25pm - 4:55pm | Methods for AMR Testing in Wastewater That Don’t Stink, Figuratively Speaking… Sponsored by: Streck |
CAP/IASLC/AMP Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors – 2021 Update Hosted by: AMP's Clinical Practice Committee |
Friday, November 17, 2023 |
||
| STAGE 1 | STAGE 2 | |
| 9:30am - 10:00am | Co-Dx PCR Home: Transforming Infectious Diseases Diagnosis Worldwide Sponsored by: Co-Diagnostics, Inc. |
TCR and BCR Repertoire Analysis and Other Approaches for the Discovery of Drug Targets, Resistance Mechanisms and Biomarkers Sponsored by: Cellecta, Inc. |
| 12:00pm - 12:30pm | Unlocking Easy, Fast, and Scalable Workflows for Optical Genome Mapping Sponsored by: Bionano |
AMP Working Group: Gene Fusions Hosted by: AMP's Clinical Practice Committee |
| 12:40pm - 1:10pm |
AMP Working Group: Cell-Free DNA Assay Validations Hosted by: AMP's Clinical Practice Committee |
Comprehensive Genomic Profiling in Oncology: Apply the AMP Guidelines for TSO-500 Variant Analysis and Clinical Reporting |
| 3:00pm - 3:30pm | From Scarcity to Sensitivity: Advancing DNA and RNA Library Prep for cfDNA Liquid Biopsy and FFPE Challenges Sponsored by: Watchmaker Genomics |
Single-Cell Copy Number Variation Confirmed, Artificial Intelligence-Driven Morphology-Based Enrichment of Malignant Cells from Body Fluid Sponsored by: BioSkryb Genomics |